Skip to main content
. Author manuscript; available in PMC: 2019 Mar 1.
Published in final edited form as: J Clin Psychiatry. 2018 Mar-Apr;79(2):17m11970. doi: 10.4088/JCP.17m11970

Table 4.

Adjusted odds ratios (AOR) for antipsychotic prescriptions among adults ages 18 and older with major depressive disorder, 2006–2015 NAMCS.

(Reference group in a parenthesis) AOR 95% CI
Race/ethnicity (Non-Hispanic White)
 Non-Hispanic Black 2.56** 1.50 – 4.36
 Hispanic 1.69** 1.16 – 2.46
 Othera) 0.93 0.47 – 1.82
Primary source of payment (Private)
 Medicare (<65) 2.16*** 1.50 – 3.10
 Medicare (≥65) 1.16 0.77 – 1.76
 Medicaid 2.06** 1.36 – 3.12
 Otherb) 1.18 0.88 – 1.57
Repeat of visits in the past 12 months (None)
 1–2 visits 1.02 0.47 – 2.20
 3–5 visits 1.12 0.53 – 2.35
 6+ visits 1.64 0.79 – 3.42
Physician specialty (Psychiatry)
 Otherc) 0.29*** 0.18 – 0.48
MSA status (MSA)
 Non-MSA 1.17 0.78 – 1.77
Mental health counseling provided (No)
 Yes 1.47** 1.12 – 1.94
Number of medications (<3)
 3+ 5.78*** 4.39 – 7.60
Adjustment disorder (No)
 Yes 0.12** 0.02 – 0.60
Cannabis use disorder (No)
 Yes 2.66* 1.17 – 6.06

Sample size
 Unweighted sample 4,044
 Weighted visits 7,976,941

F-statistic 18.26***

Note:

***

<0.001;

**

<0.01;

*

<0.05.

a)

includes Asians, American Indian/Alaska Natives (AIANs), Native Hawaiian or Other Pacific Islanders (NHOPI), and other mixed races;

b)

includes worker’s compensation, self-pay, no charge, and others; and

c)

includes primary care, general surgery, obstetrics/gynecology, orthopedic surgery, cardiovascular diseases, dermatology, urology, neurology, ophthalmology, otolaryngology, and others.